Search results for "Allergy"

showing 10 items of 3181 documents

Experimentelle Allergologie/Immunologie

2007

medicine.medical_specialtyOtorhinolaryngologybusiness.industrymedicineImmunology and AllergybusinessDermatologyAllergo Journal
researchProduct

Kontaktallergie (V 58–V 65)

2000

medicine.medical_specialtyOtorhinolaryngologybusiness.industrymedicineImmunology and AllergybusinessDermatologyAllergo Journal
researchProduct

Heat Shock Protein 70 Serum Levels Differ Significantly in Patients with Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma

2014

Members of the heat shock protein 70 (HSP70) family play an important role in assisting protein folding, preventing protein aggregation and transport of proteins across membranes under physiological conditions. Following environmental (i.e., irradiation, chemotherapy), physiological (i.e., cell growth, differentiation), and pathophysiological (i.e., inflammation, tumorigenesis) stress, the synthesis of heat shock proteins (HSPs) is highly up-regulated, whereas protein synthesis in general is reduced. In contrast to normal cells, many tumor entities including hepatocellular carcinoma (HCC) overexpress HSP70, the major-stress-inducible member of the HSP70 family, present it on their cell surf…

medicine.medical_specialtyPathologyCirrhosismedicine.medical_treatmentliver cirrhosisImmunologyInflammationmedicine.disease_causeGastroenterology03 medical and health sciencesLiver disease0302 clinical medicineInternal medicinemedicineImmunology and AllergyHCCprognostic biomarker030304 developmental biologyOriginal Research0303 health sciencesChemotherapyserum HSP70business.industryHcc ; Chronic Hepatitis ; Inflammation ; Liver Cirrhosis ; Prognostic Biomarker ; Serum Hsp70medicine.diseasePathophysiology3. Good healthHsp70HCC serum HSP70 prognostic biomarker chronic hepatitis inflammation liver cirrhosisinflammation030220 oncology & carcinogenesisHepatocellular carcinomachronic hepatitismedicine.symptomCarcinogenesisbusinessFrontiers in Immunology
researchProduct

Flare in axial spondyloarthritis. The dark side of the outcome

2016

Spondyloarthritis (SpA) is a chronic inflammatory rheumatic disease with many phenotypes,1 but the frame of the disease is still a matter of debate, particularly regarding the non-radiographic forms of axial SpA.2 ,3 The disease evolution may have several profiles, mainly related to the treatment strategy, balancing from periods of remission or low disease activity to flares of the disease. The recommended treatment strategies are supposed to be tailored to the disease activity, aiming to reach remission or low disease activity in a T2T strategy,4 with management of remission (reduction of dosage or increase in interval of administration), as well as treatment intensification in case of fla…

medicine.medical_specialtyPathologyImmunologyDiseaseInflammatory bowel diseaseGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicineRheumatologylawSynovitisSpondylarthritismedicineHumansImmunology and AllergySpondylitis Ankylosing030212 general & internal medicineIntensive care medicine030203 arthritis & rheumatologyAnkylosing spondylitisbusiness.industryEnthesitismedicine.diseaseConnective tissue diseaseRheumatoid arthritismedicine.symptombusinessFlareAnnals of the Rheumatic Diseases
researchProduct

Inflammatory mediators as biomarkers in brain disorders.

2013

Neurodegenerative diseases such as Alzheimer, Parkinson, amyotrophic lateral sclerosis, and Huntington are incurable and debilitating conditions that result in progressive death of the neurons. The definite diagnosis of a neurodegenerative disorder is disadvantaged by the difficulty in obtaining biopsies and thereby to validate the clinical diagnosis with pathological results. Biomarkers are valuable indicators for detecting different phases of a disease such as prevention, early onset, treatment, progression, and monitoring the effect of pharmacological responses to a therapeutic intervention. Inflammation occurs in neurodegenerative diseases, and identification and validation of molecules…

medicine.medical_specialtyPathologyImmunologyPopulationInflammationDiseaseBioinformaticsInternal medicinemedicineImmunology and AllergyHumansAmyotrophic lateral sclerosiseducationPathologicalSettore MED/04 - Patologia Generaleeducation.field_of_studyInflammation biomarkersbusiness.industryNeurodegenerative Diseasesmedicine.diseaseRheumatologyinflammationmedicine.symptomAlzheimer's diseaseInflammation MediatorsbusinessBiomarkers
researchProduct

2014

The objective of this cross-sectional and retrospective cohort study was (1) to determine the usefulness of intima-media thickness (IMT) in contrast to plaque assessment, (2) to examine the value of additive femoral artery sonography and (3) to identify potential risk factors for atherosclerosis and incident cardiovascular events in systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) patients. In this study, 90 SSc and 100 SLE patients were examined by duplexsonography. IMT was measured in common carotid and common femoral arteries, plaques were assessed in common, internal and external carotid and common, proximal superficial and deep femoral arteries. Different definitions of …

medicine.medical_specialtyPathologyLupus erythematosusbusiness.industryImmunologyRetrospective cohort studyFemoral arterymedicine.diseaseLower riskRheumatologyRheumatologyInternal medicinemedicine.arterymedicinePrednisoloneCardiologyImmunology and Allergyskin and connective tissue diseasesbusinessPathologicalmedicine.drugCohort studyArthritis Research & Therapy
researchProduct

PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf…

2013

Introduction: Severe adverse events have been described in children affected by Juvenile Idiopathic Arthritis (JIA) and Inflammatory Bowel Disease (IBD) treated with anti-tnf drugs. Objectives: To define the risk of severe adverse events in patients with JIA and IBD treated with anti-tnf drugs. Methods: This is a retrospective cohort study. All patients with JIA and IBD attending the "IRCCS Burlo Garofolo" of Trieste from 2000 to 2012 were enrolled. They were divided into 2 groups on the basis of the presence or absence of anti-tnf exposure. Severe adverse events were considered the followings: a) infections needing anti-tnf permanent suspension and/or hospitalization; b) autoimmune disease…

medicine.medical_specialtyPathologyPediatric onsetArthritismacromolecular substancesInflammatory bowel diseaseanti-TNF pediatric rheumatology arthritis adverse events inflammatory bowel diseaseRheumatologyinflammatory bowel diseaseInternal medicinemedicineImmunology and AllergyJuvenilePediatrics Perinatology and Child HealthPediatric rheumatologyAdverse effectbusiness.industryanti-TNFmedicine.diseaseadverse eventsdigestive system diseasesRheumatologypediatric rheumatologyarthritisPediatrics Perinatology and Child HealthPoster PresentationTumor necrosis factor alphabusiness
researchProduct

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosi…

2014

GA2LEN EAACI This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Th…

medicine.medical_specialtyPathologyUrticariahivesdiagnosisImmunologyAlternative medicine610 Medicine & healthmedicineImmunology and AllergyNetwork of excellencemedia_common.cataloged_instanceHumansGuideline developmentEuropean unionGrading (education)whealmedia_common2403 ImmunologyEvidence-Based Medicinebusiness.industryangioedemaConsensus conference10177 Dermatology ClinicGuidelineangioedema; consensus; diagnosis; hives; wheal; Evidence-Based Medicine; Humans; UrticariaSystematic reviewconsensusFamily medicine2723 Immunology and Allergybusiness
researchProduct

The concentration of para-phenylenediamine (PPD) for routine patch testing in a standard series needs to be redefined

2005

medicine.medical_specialtyPediatricsDose-Response Relationship Drugbusiness.industryDermatologyPatch TestsPhenylenediaminesPara phenylenediamineDermatologyPatch testing030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineGermany030220 oncology & carcinogenesisDermatitis Allergic ContactmedicineHumansImmunology and AllergyColoring AgentsbusinessContact Dermatitis
researchProduct

Reducing the burden of Herpes Zoster in Italy.

2015

Herpes Zoster (HZ) is a viral disease with painful neuro-dermatologic manifestations. Incidence increases with age. In Italy, the estimated incidence is 6.3 cases/1000 person/year; hospital admissions are less than 2%, 69% in patients aged over 65 years. The most frequent complication of HZ is Post-Herpetic Neuralgia (PHN) characterized by metameric pain, allodynia, and hyperalgesia. In Italy 20.6% and 9.2% of HZ patients experience PHN after 3 and 6 months, respectively. Available antiviral and analgesic treatments are relatively unsatisfactory in reducing pain and length of the disease. Prevention has recently become possible with the live attenuated vaccine Oka/Merck. Clinical studies sh…

medicine.medical_specialtyPediatricsHerpes Zoster epidemiology burden prevention immunizationSettore MED/17 - Malattie InfettiveCost-Benefit AnalysisImmunologyNeuralgia PostherpeticDiseaseSettore MED/42 - Igiene Generale E ApplicataimmunizationHerpes ZosterHerpes Zoster; epidemiology; burden; prevention; immunizationburdenChickenpox VaccinepreventionEpidemiologymedicineHumansImmunology and AllergyChickenpox VaccinePharmacologyHerpes Zoster; burden; epidemiology; immunization; preventionbusiness.industryIncidenceIncidence (epidemiology)medicine.diseaseSurgeryVaccinationAllodyniaItalyNeuralgiaepidemiologyViral diseasemedicine.symptombusinessResearch Paper
researchProduct